| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | PRASAD SUYASH | CMO and Head of R&D | Jul 05, 2022 | Sale | $3.51 | 3,905 | 13,707 | 539,545 | Jul 07, 2022, 04:30 PM | |
| TSHA | Taysha Gene Therapies, Inc. | PRASAD SUYASH | CMO and Head of R&D | Jul 06, 2022 | Sale | $3.79 | 8,956 | 33,943 | 530,589 | Jul 07, 2022, 04:30 PM | |
| TSHA | Taysha Gene Therapies, Inc. | PRASAD SUYASH | CMO and Head of R&D | Jun 29, 2022 | Sale | $3.81 | 12,324 | 46,954 | 581,265 | Jul 01, 2022, 06:55 PM | |
| TSHA | Taysha Gene Therapies, Inc. | PRASAD SUYASH | CMO and Head of R&D | Jun 30, 2022 | Sale | $3.72 | 13,892 | 51,678 | 567,373 | Jul 01, 2022, 06:55 PM | |
| TSHA | Taysha Gene Therapies, Inc. | PRASAD SUYASH | CMO and Head of R&D | Jul 01, 2022 | Sale | $3.53 | 23,923 | 84,448 | 543,450 | Jul 01, 2022, 06:55 PM | |
| TSHA | Taysha Gene Therapies, Inc. | PRASAD SUYASH | CMO and Head of R&D | Jun 29, 2021 | Sale | $23.82 | 39,218 | 934,251 | 637,533 | Jul 01, 2021, 06:32 PM | |
| TSHA | Taysha Gene Therapies, Inc. | PRASAD SUYASH | CMO and Head of R&D | Jun 30, 2021 | Sale | $21.79 | 20,076 | 437,494 | 619,997 | Jul 01, 2021, 06:32 PM | |
| TSHA | Taysha Gene Therapies, Inc. | PRASAD SUYASH | CMO and Head of R&D | Jul 01, 2021 | Sale | $21.12 | 19,706 | 416,191 | 593,589 | Jul 01, 2021, 06:32 PM | |
| BOLD | Audentes Therapeutics, Inc. | PRASAD SUYASH | Senior VP & Chief Med Officer | Jun 05, 2019 | Option Exercise | $37.31 | 757 | 28,244 | 17,479 | Jun 07, 2019, 04:42 PM | |
| BOLD | Audentes Therapeutics, Inc. | PRASAD SUYASH | Senior VP & Chief Med Officer | May 13, 2019 | Sale | $18.88 | 20,000 | 377,698 | 28,236 | May 15, 2019, 04:42 PM | |
| BOLD | Audentes Therapeutics, Inc. | PRASAD SUYASH | Senior VP & Chief Med Officer | Feb 25, 2019 | Option Exercise | $15.42 | 20,000 | 308,453 | 28,236 | Feb 27, 2019, 04:32 PM | |
| BOLD | Audentes Therapeutics, Inc. | PRASAD SUYASH | Senior VP & Chief Med Officer | Nov 15, 2018 | Option Exercise | $19.64 | 736 | 14,451 | 736 | Nov 16, 2018, 06:37 PM | |
| BOLD | Audentes Therapeutics, Inc. | PRASAD SUYASH | Senior VP & Chief Med Officer | Oct 01, 2018 | Option Exercise | $18.83 | 20,000 | 376,688 | 4,699 | Oct 02, 2018, 07:05 PM | |
| BOLD | Audentes Therapeutics, Inc. | PRASAD SUYASH | Senior VP & Chief Med Officer | Jul 02, 2018 | Option Exercise | $19.60 | 20,000 | 391,967 | 5,011 | Jul 05, 2018, 06:35 PM | |
| BOLD | Audentes Therapeutics, Inc. | PRASAD SUYASH | Senior VP & Chief Med Officer | Mar 29, 2017 | Sale | $30.02 | 7,800 | 234,195 | 0 | Mar 29, 2018, 08:23 PM | |
| BOLD | Audentes Therapeutics, Inc. | PRASAD SUYASH | Senior VP & Chief Med Officer | Mar 29, 2018 | Option Exercise | $0.79 | 7,800 | 6,162 | 7,800 | Mar 29, 2018, 08:23 PM | |
| BOLD | Audentes Therapeutics, Inc. | PRASAD SUYASH | Senior VP & Chief Med Officer | Mar 26, 2018 | Sale | $15.40 | 3,800 | 58,501 | 1,900 | Mar 28, 2018, 09:12 PM | |
| BOLD | Audentes Therapeutics, Inc. | PRASAD SUYASH | Senior VP & Chief Med Officer | Mar 27, 2018 | Option Exercise | $0.79 | 300 | 237 | 300 | Mar 28, 2018, 09:12 PM | |
| BOLD | Audentes Therapeutics, Inc. | PRASAD SUYASH | Senior VP & Chief Med Officer | Mar 27, 2017 | Sale | $30.00 | 300 | 9,000 | 0 | Mar 28, 2018, 09:12 PM | |
| BOLD | Audentes Therapeutics, Inc. | PRASAD SUYASH | Senior VP & Chief Med Officer | Dec 01, 2017 | Sale | $14.66 | 16,000 | 234,584 | 6,770 | Dec 05, 2017, 04:00 PM | |
| BOLD | Audentes Therapeutics, Inc. | PRASAD SUYASH | Senior VP & Chief Med Officer | Sep 01, 2017 | Sale | $11.11 | 16,000 | 177,801 | 8,000 | Sep 01, 2017, 05:55 PM |
Menu